BioNTech (Germany)

BioNTech (Germany)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (Germany), Germany, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

70%


Total
Publications

570


Total Open
Publications

401


Total
Citations

37K


Open Access
Percentage

70%


Total
Publications

570


Total Open
Publications

401


Total
Citations

37K

Wikipedia

Website

download

Breakdown

21% 36% 13% 30%

Publisher Open

21%

Both

36%

Other Platform Open

13%

Closed

30%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

49%OA Journal

OA Journal 49%

155

Hybrid 27%

83

No Guarantees 24%

76

Other Platform Open

Domain 72%

196

Preprint 18%

50

Institution 17%

45

Other Internet 12%

32

Public 1%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
195
DOI
Other Internet
32
bioRxiv
Preprint
30
Europe PMC
Domain
12
medRxiv
Preprint
11
Royal Netherlands Academy of Arts and Sciences
Institution
7
Research Square
Preprint
6
ZB MED - Information Centre for Life Sciences
Institution
5
Swiss School of Archaeology in Greece
Institution
3
Preprints
Preprint
3
1 / 4

Data updated 18 August 2025

Share

Share

Share